Connexin 43 and CaV1.2 Ion Channel Trafficking in Healthy and Diseased Myocardium.
From the Heart Institute and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (W.A.B., R.M.S.); and Department of Medicine, University of California Los Angeles (R.M.S.).
Wassim A
WA
Basheer
From the Heart Institute and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (W.A.B., R.M.S.); and Department of Medicine, University of California Los Angeles (R.M.S.). Robin.Shaw@cshs.org.
Robin M
RM
Shaw
D020746:Calcium Channels, L-Type / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000378:metabolism* / Q000503:physiopathology*; D018031:Connexin 43 / Q000378:metabolism*; D017629:Gap Junctions / Q000378:metabolism*; D006207:Half-Life; D015640:Ion Channel Gating / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism*
D020746:Calcium Channels, L-Type; D018031:Connexin 43; C419385:L-type calcium channel alpha(1C)
calcium channels; connexins; gap junctions; ion channel; mutation